跳至主要内容
临床试验/NCT04005599
NCT04005599已完成不适用

Magnesium Sulfate in Substitution to Remifentanil. Intra-operative Analgesia Assessed by the Surgical Stress Index. Randomized and Blind Clinical Trial

University of Sao Paulo General Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年6月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Feasibility of using magnesium sulfate as analgesic of venous general anesthesia

研究概览

简要总结

Magnesium sulfate has been shown to be useful in many situations in medicine, such as eclampsia prevention and treatment, pulmonary hypertension, arterial pressure, asthma, cardiac arrhythmias and pheochromocytoma. Recently there has been a growing a big interest in this drug as an useful adjuvant in anesthesia, with analgesic and anesthetic sparing effect, antihyperalgesic property and potentialization of the neuromuscular blocker agent effect. On the other hand there has been a growing concern related to opioid administration, such as hyperalgesia, delayed return of intestinal function and the (still controversial) possibility of facilitating effect on tumor growth and metastases in cancer patients.

This project is based on a previous randomized, double blind prospective trial (conducted by one of these authors and not yet published) comparing two groups of patients who received general intravenous total anesthesia with propofol in controlled target infusion.

The surgical stress index is obtained by the interaction between the interval between heart beats and the amplitude of the photoplethysmography wave, whose algorithm generates a number related to the hemodynamic result of the increase of the sympathetic tone, which has shown to be the most sensitive resource in detecting the imbalance between the stimulus nociceptive and anti-nociception.

详细描述

Magnesium sulfate has been shown to be useful in many situations in medicine, such as eclampsia prevention and treatment, pulmonary hypertension, arterial pressure, asthma, cardiac arrhythmias and pheochromocytoma. Recently there has been a growing a big interest in this drug as an useful adjuvant in anesthesia, with analgesic and anesthetic sparing effect, antihyperalgesic property and potentialization of the neuromuscular blocker agent effect. On the other hand there has been a growing concern related to opioid administration, such as hyperalgesia, delayed return of intestinal function and the (still controversial) possibility of facilitating effect on tumor growth and metastases in cancer patients.

This project is based on a previous randomized, double blind prospective trial (conducted by one of these authors and not yet published) comparing two groups of patients who received general intravenous total anesthesia with propofol in controlled target infusion.

The surgical stress index is obtained by the interaction between the interval between heart beats and the amplitude of the photoplethysmography wave, whose algorithm generates a number related to the hemodynamic result of the increase of the sympathetic tone, which has shown to be the most sensitive resource in detecting the imbalance between the stimulus nociceptive and anti-nociception.

Objectives The main objective of this project is to evaluate the feasibility of the use of magnesium sulfate in replacement of remifentanil as the main analgesic agent in total venous general anesthesia in patients submitted to post-bariatric dermolipectomy surgery.

The secondary objectives will be comparison of propofol consumption, time to onset of action, time of action and cisatracurium consumption between groups. We will evaluate pain scores in the immediate postoperative period and in the mornings and afternoons of the 3 days after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The anesthesiologist in charge of randomization will number 40 opaque envelopes and insert a card in each with the corresponding information of the group (according to the lottery) and the medication to be administered. Another anesthesiologist in charge of preparing the blind solution alone will open the envelope. Both of these investigators, as well as the anesthesiologist providing anesthesia and the anesthesiologist in charge of data evaluation will not participate in any of the other steps of the trial. The patients will be blinded to their own treatment group.

入排标准

年龄范围
18 Years 至 18 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • age 18 to 60 year-old
  • body mass index < 35 kg/m²
  • American Society of Anesthesiologists score < III
  • agreement to participate and sign the informed consent form.

排除标准

  • Allergy to any medications of the trial
  • neuromuscular diagnosed disorder
  • cardiac conduction blockade (atrioventricular block II or higher),
  • use of illicit drugs
  • use of calcium channel blockers
  • creatinine > 2 mg/dl.

研究组 & 干预措施

Remifentanil group

Active Comparator

Intravenous anesthesia with propofol and remifentanil

干预措施: Remifentanil group (Drug)

Magnesium group

Experimental

Intravenous anesthesia with propofol and magnesium sulfate

干预措施: Magnesium sulfate group (Drug)

结局指标

主要结局

Feasibility of using magnesium sulfate as analgesic of venous general anesthesia

时间窗: Surgery time

Changes in systolic blood pressure (mmHg) after tracheal intubation and surgical incision in both groups.

次要结局

  • Neuromuscular blocker action(During surgery)
  • Anesthetic consumption.(During surgery)
  • Postoperative pain(Three days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joaquim Edson Vieira

Associate professor

University of Sao Paulo General Hospital

研究点 (1)

Loading locations...

相似试验